FDA Approves lupin to copy trizivir tablets
-
Last Update: 2013-12-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: lupin Co., Ltd., a multinational pharmaceutical enterprise led by innovation of China Council for the promotion of drugs on December 10, 2013, announced that its 300 mg / 150 mg / 300mg tablets of abakavir sulfate, lamivudine and zidovudine were approved by FDA for listing, which is a generic drug of trizivir 300 mg / 150 mg / 300mg tablets, a brand drug of VIV healthcare Lupin's 300 mg / 150 mg / 300 mg tablets of abacavir sulfate, lamivudine and zidovudine can be combined with other antiretroviral drugs or used alone for the treatment of HIV-1 infection Lu Ping is the first company to submit an anda application for imitating trizivir film, so he will enjoy a 180 day market monopoly period According to IMS mat data in September 2013, the annual sales of trizivir 300 mg / 150 mg / 300 mg tablets in the United States is about 116 million US dollars Original link: http://www.rttnews.com/2236627/lupin-receives-fda-approval-for-generic-trizivir-tables.aspx
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
